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Abstract 
Betanodavirus infection causes fatal disease of viral nervous necrosis in many cultured marine and freshwater fish 
worldwide and the virus-like particles (VLP) are effective vaccines against betanodavirus. But vaccine and viral vec-
tor designs of betanodavirus VLP based on their structures remain lacking. Here, the three-dimensional structure of 
orange-spotted grouper nervous necrosis virus (OGNNV) VLP (RBS) at 3.9 Å reveals the organization of capsid proteins 
(CP). Based on the structural results, seven putative important sites were selected to genetically insert a 6× histidine 
(His)-tag for VLP formation screen, resulting in four His-tagged VLP (HV) at positions N-terminus, Ala220, Pro292 and 
C-terminus. The His-tags of N-terminal HV (NHV) were concealed inside virions while those of 220HV and C-terminal 
HV (CHV) were displayed at the outer surface. NHV, 220HV and CHV maintained the same cell entry ability as RBS in 
the Asian sea bass (SB) cell line, indicating that their similar surface structures can be recognized by the cellular entry 
receptor(s). For application of vaccine design, chromatography-purified CHV could provoke NNV-specific antibody 
responses as strong as those of RBS in a sea bass immunization assay. Furthermore, in carrying capacity assays, N-ter-
minus and Ala220 can only carry short peptides and C-terminus can even accommodate large protein such as GFP to 
generate fluorescent VLP (CGV). For application of a viral vector, CGV could be real-time visualized to enter SB cells in 
invasion study. All the results confirmed that the C-terminus of CP is a suitable site to accommodate foreign peptides 
for vaccine design and viral vector development.
© 2016 Xie et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Piscine nodaviruses, the causal agents of viral nervous 
necrosis (VNN) or viral encephalopathy and retinopathy 
(VER), are members of the Betanodavirus Nodaviridae 
family. Betanodaviruses are small, spherical, non-envel-
oped viruses with a bipartite single-stranded (+) RNA 
genome encapsulated by 180 molecules of a single self-
assembly capsid protein (CP) [1]. They are important 
viruses in aquaculture because they can infect more than 
40 marine fish species [2], especially high-value fish spe-
cies, primarily at the larval and juvenile stages [3], which 
results in mass mortality and serious economic losses. 
To effectively control the disease, vaccine against betan-
odavirus is a pivotal strategy with general acceptance. 
Several types of vaccines have been reported, including 
poorly protective vaccines constituting recombinant CP 
[4, 5] or synthetic peptides derived from CP [6] as well 
as effective vaccines containing inactive betanodaviruses 
[7–9] or virus-like particles (VLP) [10–12]. VLP are well-
structured particles with high similarity to native virions 
and they can assemble spontaneously from single (i.e. 
betanodavirus CP) or multiple structural proteins under 
specific conditions [13, 14]. VLP can be produced either 
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eukaryotically or prokaryotically, and prokaryotic VLP 
production, in particular, presents advantages of high 
production, short duration, low cost, and easy manipu-
lation. Theoretically, VLP are not infectious and they are 
safer than attenuated vaccines because of not containing 
viral genomes. Therefore, VLP is one of the most promis-
ing models for vaccine research and virology study.
Structural information of VLP is important in aiding 
vaccine design, modification or remodeling to develop 
the viral carriers (antigens or nucleic acids carrying vec-
tors) with surface display techniques [15], to exploit 
multivalent vaccines [16], to manipulate the tropism 
of infection [17], and to achieve easy purification dur-
ing vaccine production [18]. Cryo-Electron microscopy 
(cryo-EM) that allows visualization of macromolecules 
in their native state has been used to obtain the struc-
tural information of many virus particles. Combined with 
techniques of three-dimensional (3D) reconstruction, 
cryo-EM images of macromolecules can be used to study 
the high-resolution structure and interactions of macro-
molecules, helping to reveal the functions of assembly 
and invasion machineries of viral capsids. Several atomic 
resolution structures of virus (or VLP) and protein com-
plexes have recently been reported [19, 20].
The OGNNV VLP was successfully produced prokar-
yotically and proved to be an effective vaccine against 
OGNNV [12]. In the present study, we want to verify 
the possibility of modification of betanodavirus VLP to 
achieve the purposes of vaccine research and viral vector 
development. Firstly, the 3D structure of native OGNNV 
VLP (RBS) at 3.9 Å resolution was determined. Not only 
the secondary structures but also some side-chain den-
sity were well defined and allowed us to identify the puta-
tive important sites for accommodating foreign peptides. 
Secondly, based on structural information, 6×  histi-
dine (His) tag and green fluorescent protein (GFP) were 
inserted into different positions by genetic approach to 
verify the importance of the predicted key sites by VLP 
production rate. The inward/outward displaying status 
and the carrying capacities of the sites of modified VLP 
were also verified. Finally, the potential applications of 
easily purified vaccines and viral carriers inserted at the 
C-terminal site were tested. Our results prove betanoda-
virus VLP can be modified by insertion and suggest the 
key sites for accommodating foreign peptides for the pur-
pose of vaccine research and viral vector development.
Materials and methods
VLP production and purification
Full length cp gene of OGNNV (GenBank: AF534998) 
was cloned into modified pQE30 (Qiagen) and expressed 
prokaryotically in M15 Escherichia coli as described [12]. 
VLP were produced as follows. A volume of 80 mL seed 
culture grown overnight at 37 °C was inoculated equally 
into 8 flasks of 1 l LB-broth medium supplemented with 
100 μg/mL ampicillin. When the cell density reached an 
OD600 of 0.3–0.4, the culture was cooled down to 30 °C 
and 0.9 mM IPTG was added for induction. After induc-
tion for 2 h at 30 °C, cells were harvested by centrifuga-
tion (5000  × g, 4  °C, 20  min), resuspended in 100  mL 
lysis buffer (pH 8.0 PBS with 1% Triton X-100 and 2 mM 
PMSF), lysed by sonication and centrifuged at 40 000 × g 
for 20 min. The whole cell pellets, supernatants and cell 
debris were saved for SDS-PAGE for a solubility test. Col-
lected supernatant was ultracentrifuged at 250 000  × g 
(Beckman Optima L-100XP) for 1  h against a 30% 
sucrose cushion. The pellet was resuspended in 4 mL of 
PBS (pH 8.0) and further purified using a 10–40% (w/w) 
sucrose gradient and ultracentrifuged at 250 000 × g for 
3  h. Fractions of various buoyancies were collected and 
examined by SDS-PAGE and immunoblotting. The shape, 
size and integrity of the VLP were confirmed by the 
negative staining and transmission electron microscope 
(TEM) (JEOL JEM-1400) observation. The fractions con-
taining fine structured and highly pure VLP were diluted 
with PBS and ultracentrifuged at 250 000 × g for 1 h to 
remove the sucrose. The pellets were resuspended with 
PBS and the VLP (RBS or the modified VLP) were veri-
fied again by TEM. RBS was stored for the 3D structure 
research. Purified VLP were applied to SDS-PAGE and 
BCA Protein Assay Kit (Thermo) to determine the con-
centration and stored at −80 °C until use.
Cryo‑EM imaging, 3D reconstruction and model building
A 3.5 μL aliquot of the RBS sample was applied to a 
JG holey grid and blotted for 3  s in a chamber at 100% 
humidity and flash frozen using an FEI Vitrobot Mark 
IV. Particles were imaged with an FEI 300 kV Titan Krios 
cryo-electron microscope equipped with a Gatan Ultra-
Scan4000 16-megapixel CCD at nominal magnification 
of 96 000×, corresponding to a final pixel size of 0.933 Å. 
The total dose was approximately 20 e−/Å2. The defocus 
values ranged from −1.0 to −3.0 µm.
Particles were picked up from the micrographs using 
the e2boxer.py program in EMAN2 [21] and the contrast 
transfer function parameters were determined using 
EMAN1.9 [22]. Article images (32 000) from 1359 frames 
were used in the final reconstruction. The data were ran-
domly separated into two independent groups and JSPR 
was used to refine the center, orientation, defocus, astig-
matism, and magnification of each particle and rebuild 
the final density map [23]. The resulting density maps 
were sharpened by applying the B-factor using the proc3d 
in EMAN1.9 [22]. The resolution was assessed using the 
gold-standard by the 0.143 FSC criterion [24]. The local 
resolution was also calculated using the two independent 
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reconstructions from halves of the total particles by Res-
Map [25].
All the protein subunit segmentation and visualiza-
tions were finished using UCSF Chimera [26]. The CP 
sequence was used to build a comparative model by 
Phyre2 [27]. The model was then fitted into the density 
map using the ‘‘fit into map’’ module in UCSF Chimera 
[26] according to the previously reported methods [28]. 
Further refinement and optimization was done by the 
Coot [29] and Phenix [30]. Finally, we used the refined 
model instead of the initial comparative model to guide 
the segmentation of its corresponding density.
Plasmid construction
Primers NHV-L and CP-R or RBS-L and CHV-R were 
used to amplify the cp gene from cDNA of RNA2 and the 
product was then inserted into pQE30 (Qiagen) using SacI 
and HindIII or EcoRI and HindIII sites to generate pQE-
His-CP or pQE-CP-His, respectively. These plasmids are 
used for expression of 6× His-tagged CP at N- or C-ter-
minus. To generate the plasmids for expression of inter-
nal 6×  His-tagged CP, overlap PCR was performed. The 
primers RBS-L and CP220HD/CP254HD/CP286HD/
CP292HD/CP301HD or CP220HU/CP254HU/CP286HU/
CP292HU/CP301HU and CPTAA-R were used to amplify 
the cp gene to generate upstream or downstream interme-
diate amplicons (IA). The corresponding upstream and 
downstream IA were purified and used as templates for 
amplifying by RBS-L and CPTAA-R to generate the final 
amplicons. The final amplicons were inserted into pQE30 
using EcoRI and HindIII sites to generate five internal His-
tag inserted plasmids, pQE-220HisCP, pQE-254HisCP, 
pQE-286HisCP, pQE-292HisCP, and pQE-301HisCP, 
for expression of internal 6 ×  His tagged VLP. The plas-
mid for expression of native VLP, namely RBS, is pQE-CP 
[12]. Overlap PCR was also performed to generate GFP-
tagged CP. The primers EGFPNL/EGFPCL and EGFPNR/
EGFPCR or NGV-L/CGV-L and CP-R/CGV-R were used 
to amplify egfp or cp gene to generate IA. The resulting 
IA were purified and used as template for amplifying by 
EGFPNL/CGV-L and CP-R/EGFPCR to generate the final 
amplicons of N-terminal or C-terminal tagged CP. For 
220GFP-CP, the primers CGV-L/EGFPCL/220GV-L and 
220GV-R/EGFPNR/CP-R were used to amplify three IA 
that were subsequently used as templates for two rounds 
of overlap PCR. All the final amplicons were inserted 
into pRSET-A (Invitrogen) using XbaI and HindIII sites. 
The resulting plasmids were named as pR-GFPCP, pR-
220GFPCP and pR-CPGFP. All of these plasmids were 
transformed into M15 E. coli cells for expression. Sonica-
tion and gradient purification were performed to verify 
the production of different VLP as mentioned above. The 
primers used here are listed in Additional file 1.
Immuno‑EM
RBS or HV were applied onto carbon-filmed grids, 
left for 15 min, and blotted until nearly dry. Grids were 
then blocked by incubation face down on drops of 2% 
bovine serum albumin (BSA) for 30  min. Grids were 
incubated for 1 h with mouse anti-His monoclonal anti-
body (EarthOx, USA) at 100-fold dilution or mouse anti-
VLP sera (polyclonal antibody produced in-house, total 
immunoglobulin) at 200-fold dilution. After that, grids 
were incubated for 1 h with goat anti-mouse IgG conju-
gated to 5 nm gold particles (Sigma) at 50-fold dilution. 
All incubations were performed at room temperature 
and grids were washed 3 times with 0.05% PBS-Tween 
20 (vol/vol, PBST) between each step from the blocking 
step. VLP and gold particles were confirmed by negative 
staining and TEM observation.
VLP invasion assay
The invasion assays were performed using RBS, HV and 
CGV on OGNNV-sensitive Asian sea bass (Lates cal-
carifer) fibroblast (SB) cells as previous described [12]. 
In brief, SB cells were grown on coverslip at 26 °C. VLP 
(0.3 μg/μL) diluted in minimal essential medium (Gibco) 
were incubated with SB cells at 0 °C for 1 h for attachment 
and invasion synchronization. After being thoroughly 
washed with PBS to remove excessive VLP, SB cells were 
received fresh medium and were switched to 26  °C to 
trigger invasion for 1.5  h. For observation of CGV in 
real-time, fluorescent microscopy was performed at the 
indicated time. For indirect immunofluorescence assays 
(IFA) [31], media were removed and cells were fixed with 
4% paraformaldehyde for 30 min and then permeabilized 
for 5  min in 0.2% PBS-Triton X-100 (vol/vol) at room 
temperature. The cells were washed with 0.05% PBST (all 
wash steps below indicate three times of 0.05% PBST) 
and blocked with 5% FBS. IFA was performed at room 
temperature by incubating cells for 1 h with mouse anti-
His monoclonal antibody (EarthOx, USA) at 500-fold 
dilution or mouse anti-VLP sera at 1000-fold dilution as 
primary antibodies. Cells were washed and treated with 
Alexa Fluor 488-labeled goat anti-mouse IgG antibody 
(Life technologies) at 1000-fold dilution as the secondary 
antibody for 1  h. Cells were washed and the cell nuclei 
were counterstained in red with PI (Sigma). Fluorescent 
microscopy was carried out using a Nikon Eclipse Ti flu-
orescent inverted microscope, and images were analyzed 
using Nikon NIS Elements imaging software (Br2 v3.21) 
to determine the location of virions.
Affinity chromatography of HV
As described above for VLP production, cells express-
ing HV were induced, harvested, resuspended and soni-
cated in lysis buffer with addition of 10  mM imidazole. 
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After centrifugation, a one bed volume of the collected 
supernatant was mixed with a half bed volume of nickel-
nitrilotriacetic acid (Ni–NTA) matrices (Qiagen) that 
had been previously washed three times with lysis buffer 
for 2  h at 4  °C with rotation. The matrices were then 
washed six times with three bed volume of wash buffer 
(lysis buffer with addition of 26  mM imidazole) with 
15 min rotation during each wash. Proteins bound to the 
matrices were eluted with a one bed volume of elution 
buffer (lysis buffer with addition of 250  mM imidazole) 
for 30 min at 4 °C with rotation. The eluted proteins were 
concentrated and the buffer was exchanged with PBS 
using Amicon® Ultra Centrifugal Filters (Merck Milli-
pore) according to the manufacturer’s instructions. Puri-
fied HV were subjected to SDS-PAGE and BCA protein 
assay kit (Thermo) for concentration determination, and 
to EM for structural completeness evaluation. Purified 
HV were stored at −80 °C until use.
Sea bass immunization and antibody response detection
Healthy Asian sea bass juveniles with an average body 
weight of 5 g were maintained in flow-through freshwa-
ter at room temperature, aerated with an air pump and 
acclimated to the system for 3 days, at which time tissues 
were collected from 6 random fish for virus-free test and 
as control samples before injection (0  h). Feeding was 
suspended 12  h before vaccination and sampling. Sea 
bass were divided equally into ten groups with 40 fish per 
group. Two independent trials were conducted to deter-
mine the impact of immunization times (once and twice) 
to the vaccination efficiency and a 1-week interval was 
set before the booster. RBS or CHV were injected intra-
muscularly at doses of 15  μg/g fish body weight (FBW) 
as high concentration groups (V.H.: high concentration 
RBS; H.H.: high concentration CHV) or 1.5 μg/g FBW as 
low concentration groups (V.L. low concentration RBS, 
H.L. low concentration CHV) into the dorsum of anes-
thetized sea bass. PBS was also injected as negative con-
trols. For antibody detection, thirty fish from each group 
in each trial were randomly selected. At indicated sam-
pling time points (every week) post-immunization, fish 
sera were collected from the caudal vein and combined as 
one sample. Antibody titers of anti-VLP sera were deter-
mined by antigen-capture ELISA. All the experimental 
protocols concerning the handling of fish were in accord-
ance with the requirements of the Institutional Animal 
Care and Use Committee of Sun Yat-sen University, P. R. 
China.
Antigen‑capture ELISA
Antigen-capture ELISA was performed as described 
[12] to determine the antibody titers of anti-VLP sera. 
In brief, 50 μL of diluted fish sera (1:100) were coated in 
a well of 96-well microtiter plate at 4  °C overnight. The 
plate was conducted to room temperature and washed 
three times with 200 μL PBS. After blocking with 5% 
BSA in PBS for 1  h and washing three times with 1% 
PBST (all wash steps below indicated three times of 
200 μL 1% PBST), 1 ng VLP was added to each well and 
incubated for 1  h. After wash, the plate was incubated 
with in-house produced mouse anti-VLP antiserum at a 
dilution of 1:1000 in PBST for 1 h. The plate was washed 
and peroxidase-conjugated goat anti-mouse IgG (Sigma) 
at a dilution of 1:3000 was added and incubated for 1 h. 
Following thorough washes (five times), 100 μL of OPD 
substrate (Sigma) was added and the color development 
was conducted at room temperature. The reaction was 
stopped by the addition of 4  M sulfuric acid and the 
absorbance at 492  nm was determined. Statistical dif-
ferences of titers from different groups were assessed 
by paired Student’s t tests. Numerical results are pre-
sented as mean  ±  standard deviation with 95% confi-
dence intervals and p < 0.05 was considered statistically 
significant.
Results
The features of RBS capsid
Final density map of the RBS capsid reconstructed by 
JSPR was estimated at 3.9 Å based on the “gold” stand-
ard FSC  =  0.143 criterion (Additional file  2) (EMDB 
6453). The 3D structure of RBS (Figures  1A  and B) 
reveals that RBS has a capsid with 30  nm in diameter 
with T  =  3 icosahedral symmetry (Additional file  3). 
Outside of the surface of the capsid, there are 60 pro-
trusions located at the top of the center of each asym-
metry unit, and with the protrusions, the diameter of 
the whole RBS enlarges to be around 38 nm (Figure 1C). 
There are three chemical identical subunits with slight 
conformational variations in the spatial location, VPa, 
VPb and VPc, in each asymmetric unit (Figures 1D and 
E) (also see Additional file 4). At current resolution, the 
alpha helix and beta sheets could be clearly identified, 
and most β-strands in the capsid were already separated 
(Figures 1D and E). Some distinctive side chains on heli-
ces, β-strands and loops could be identified (Figure 1F). 
Inside the capsid, there are some densities which belong 
to the randomly packaged RNA (Additional file  3). It 
was difficult to figure out the pattern of the RNA and 
the density became much weaker as the resolution was 
improved, because the reconstruction imposes icosahe-
dral symmetry while the RNA should not be in the same 
symmetry.
A model for the capsid protein was built (PDB 3JBM) 
based on the density map at current resolution. Five VPa 
contribute to the densities around five-fold axis. VPb and 
VPc compose the densities of the hexagons together. We 
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could only identify the densities of residues 52–220 of 
VPa and VPb. While for VPc, we could detect the den-
sities of 17 more amino acid residues at the N-terminal 
(Figures 1D and E). These 17 amino acids compose a loop 
from the two fold axis and cross the VPb (Figure 1), then 
form a trident structure with another two N-terminus of 
the VPc at the three fold (Additional file 5).
Based on the density map and the model of the capsid, 
both N-terminals of the VPa, VPb and VPc are inside 
the capsid. If we low-pass the density map to 8 Å, three 
linker densities (residues 210–220) from each subunit 
of the asymmetry unit could be demonstrated connect-
ing capsid shell to the protrusions at residues 220. There 
is no doubt that the protrusions densities belong to the 
residues 220–338, the C-terminus of the capsid protein. 
Accordingly, we separate CP into three independent 
domains: the N-terminal domain (N domain) (residues 
1–50), the Shell domain (S domain) (residues 51–220) 
and the Protrusion domain (P domain) (221–338). The S 
domain is mainly composed of a canonical jelly-roll, and 
a β-barrel fold containing eight antiparallel β-strands. 
The S domain by itself forms a continuous capsid shell 
without any notable holes.
The flexible protrusions and the putative sites for insertion 
study
Three P domains of VPa, b and c composed a trim-
eric protrusion in each asymmetry unit. Between S 
and P domains, there is a high flexible linker loop com-
posed of residues 210–220 functioning as a connection 
(Figure 1C). The flexible linker loops are responsible for 
the spatial variation of the protrusions.
Our map demonstrates that the spatial variable pro-
trusions outside the capsid are at relative low resolu-
tion. Local resolution analyses by ResMap show that the 
resolution of protrusion density is even worse than 10 Å 
(Additional file 6), resulting in no structural details of the 
protrusions being identified. Although protrusions have a 
low resolution, the structure we obtained allows identify-
ing some residues for putative sites for VLP modification. 
Furthermore, the fine structure of capsid shell indicates 
that the insertion may influence the organization of 
VLP. Therefore, the modification study was focused on 
the protrusions and linker loops in order to display the 
foreign peptide. As a negative site for the virion surface 
displaying, the N-terminals are located inside the capsid 
shell. Consequently, residues 0 (N-terminus), 220, 254, 
Figure 1 Three dimensional structure of OGNNV VLP (RBS). A The outside view of the RBS capsid. The red triangle demonstrates an asym-
metry unit and the digits of 5, 3 and 2 show the position of the five, three and twofold axis. B The cut-way view shows the inward structure of the 
RBS capsid. The color bar shows the color scheme in the radius. The contour of A and B is 3.5. C The left one shows the surface map of RBS with 
the contour of 1.2. The color scheme is the same as A and B. It demonstrates that there are 60 protrusions outside the capsid shell, and the zoom 
in view (low passed to 8 Å) shows there are three linker loops that link the protrusion to the capsid. The red circles demonstrate the location of the 
residue Ala220. The contour of the right one is 0.6. D, E are the outside and inside view of an asymmetry unit density map superimposed by their 
models, respectively. The density maps are in gray, and the ribbon models of VPa, VPb and VPc are colored in golden, cornflower blue and purple, 
respectively. The outside view shows that the Ala220 residue (red circle) is at the surface of the capsid, while the inside view shows that all the 
residues of the N-terminal of the VPa and VPb (blue circles) are inside the capsid. For the VPc, 17 more residues which belong to the N domain form 
a loop (black arrow) across the VPb. F The features of a fragment of helix (left) and loop (right) at current resolution obviously demonstrate the big 
side chain densities. The models in golden color are superimposed in the density map (gray mesh). The contour of the map shown here is 3.2.
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286, 292, 301, and 338 (C-terminus) of CP were selected 
as potential targets for subsequent insertion study.
Modified VLP production
Based on the structure and model, we inserted a 6× His-
tag into seven different positions of CP connected with 
flexible peptides as indicated in Figure 2A. All HCP were 
subjected to SDS-PAGE and immunoblotting to verify 
their expression and solubility after prokaryotic expres-
sion, sonication, and centrifugation (Figure 2). All of the 
HCP were correctly expressed after optimization except 
for 286HCP, which was expressed in very small quanti-
ties. However, the soluble forms of 292HCP and 301HCP 
were far less than those of other HCP (Additional file 7). 
Accordingly, the sequence of amino acid residues around 
positions Ala286, Pro292, and Trp301 were essential 
for CP expression and solubility. After sucrose gradient 
ultracentrifuge purification of the supernatants, we got 
tagged VLP of N-terminal HV (NHV), 220HV, 292HV, 
and C-terminal HV (CHV) (Figure 2B). Surprisingly, the 
highly expressed and soluble 254HCP is maintained as a 
monomer and cannot form VLP, suggesting that the posi-
tion 254 of CP is important for VLP formation. Although 
different HV with shapes similar to that of RBS were 
produced, their quantities were remarkably different, as 
shown in Figure 2C. Comparing with the production of 
RBS (100%), the final quantities of NHV or CHV in the 
same culture volume were 89  ±  12.7% or 96  ±  13.3% 
while the amount of 220HV was 124 ±  13.2% and that 
of 292HV was less than 8% of RBS. 301HCP was unable 
to form sufficient amounts of particles (301HV, data not 
shown) for standard gradient ultracentrifugation, esti-
mating that the production of 301HV was less than 1% 
of the RBS production. Furthermore, the broken parti-
cles were more frequently seen in 292HV and 301HV 
than in NHV, 220HV, and CHV. These results suggest 
that the internally inserted His-tag may influence the 
formation of highly structured particles while the inser-
tions at N-/C-termini and linker loop were less affected. 
These results were consistent with the structural analysis, 
because the N-/C-termini and the linker loop are located 
far from the interaction domains and functional sites. 
Therefore, NHV, 220HV, and CHV were selected for fur-
ther study because of their higher yields.
Surface display of His‑tag on HV verified by immuno‑EM
Immuno-EM assays of purified HV were performed to 
determine whether or not the His-tag presents at the 
surface of HV. The mouse anti-His antibodies and gold-
labeled goat anti-mouse antibodies were used to detect 
surface displaying His-tags on fine structured VLP. As 
shown in Figure 3A, gold particles could be seen clearly 
around the 220HV and CHV but not be presented in the 
marginal places without VLP. This finding demonstrates 
that the His-tag is displayed on the surface of 220HV 
and CHV. NHV cannot be labeled with gold particles, 
which is similar to the negative control (RBS), suggest-
ing that the N-terminal His-tag is not exposed outside of 
NHV. Structural information indicates that the trend of 
the N-terminal His-tag should be partially linked to the 
enclosed nucleic acid, which corresponds to the immune-
EM results. By contrast, all types of VLP could be labeled 
with gold particles using polyclonal anti-VLP antisera 
(Figure 3B). These results indicate that the displayed His-
tags do not affect the binding of anti-VLP antibodies.
Cell entry ability of HV
VLP invasion assays were performed to verify the entry 
process of HV and determine whether or not the dis-
played His-tags alter the surface structure of HV. Theo-
retically, the same entry process and comparative entry 
Figure 2 Prokaryotic expression of HV. A His-tag insertion design 
and the additional amino acid sequences. NHCP represents the 
N-terminal His-tagged CP, IHCP represents the internal His-tagged 
CP, and CHCP indicates the C-terminal His-tagged CP. The black 
blocks represent CP. B Electron microscopy of RBS and different HV. 
Magnification is 30 k and the bar indicates 100 nm. C Production 
ratio of different VLP in the same expression volume. The ratios were 
generated by normalization of production of HV to that of RBS. All 
the data represented means for at least 10 batches of VLP preparation 
with 2 standard deviations indicated by the error bars.
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ability should be observed in the entry assays of HV and 
RBS if the surface structures of these particles are simi-
lar. In the assays, SB cells were incubated with HV, and 
RBS served as the positive control. The particles that 
had successfully entered were visualized by IFA. NHV, 
220HV and CHV can enter SB cells via a pattern similar 
to that of RBS, as detected by IFA using anti-VLP anti-
body (left column of Figure  4). The particle entry was 
completed within 1.5 h and the particles aggregated next 
to or around the cell nuclei, indicating rapid endocyto-
sis and they accumulate in some endosome-like com-
partments. These results demonstrate identical entry 
abilities between HV and RBS. Furthermore, the His-
tags of 220HV and CHV could be detected by anti-His 
antibodies whereas the His-tag of NHV could not be 
labeled (right column of Figure  4). These findings were 
in accordance with the results of immune-EM. The inva-
sion assays demonstrate that both native VLP (RBS) and 
modified VLP (HV) can specifically bind to the virus 
entry receptor(s) on the cell membrane and enter SB cells 
via the same endocytic pathway. Thus, the outer shell 
of HV is structurally indistinguishable from that of RBS 
or native virus, and the His-tags do not change the cell 
tropism of HV. By detecting the His-tags, HV and native 
VLP or viruses can be easily distinguished by immunoas-
say. Moreover, the key sites, such as Ala220 in the linker 
loop and C-terminus of CP, are excellent positions for 
accommodating foreign peptides on the outer surface 
of virions, exhibiting the potential application for viral 
vectors.
Chromatographic purification of HV
As an application of vaccine design for tagged VLP, we 
decided to test the purification function of His-tag by 
affinity chromatography because the tags are present on 
the surface of 220HV and CHV. Bacteria expressing RBS, 
220HV, and CHV were harvested and broken by sonica-
tion. After centrifugation, the supernatants were purified 
by Ni-NTA beads and the purification results are shown 
in Figure  5. As an alternative method for VLP purifica-
tion, affinity chromatography was used to purify 220HV 
and CHV, as detected by SDS-PAGE and immunoblotting 
(Figure 5A). Moreover, the purified products maintained 
Figure 3 Immuno-EM of different kinds of VLP. RBS, NHV, 220HV, 
and CHV were immune-labeled with gold particles using mouse anti-
his antibodies (A) or mouse anti-VLP sera (B) as the first antibody as 
indicated. The black dots are the 5 nm gold particles conjugated with 
goat anti-mouse secondary antibodies and the bars indicate 100 nm.
Figure 4 HV maintained the cell entry ability. The purified RBS 
and three types of HV were used to perform cell invasion assays. After 
1.5 h incubation, the cells were fixed and IFA were performed using 
anti-His antibodies (left panels) and anti-VLP sera (right panels). The 
VLP in cells were labeled in green and the cell nuclei were counter-
stained in red. The His-tags of HV were stained positively when they 
were presented at the surface of the virions. The bar indicates 25 µm.
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the fine VLP structure, as revealed by EM (Figure  5B). 
Without the His-tag, RBS could not be enriched during 
purification. Moreover, the resulting quantities of 220HV 
and CHV produced from 1 L cell culture volume were 
3.63 ±  0.55 and 3.84 ±  0.46  mg/L, respectively. Appar-
ently, CHV was more effective than 220HV in affinity 
chromatography because the production quantities of 
220HV were 29% more than those of CHV when using 
the ultracentrifugation method. This result suggests that 
the His-tags presented on the C-terminus are more suc-
cessful than those displayed on Ala220 of the linker loop. 
The chromatography-purified HV can be used directly 
as vaccine although the concentration is lower than that 
obtained by ultracentrifugation. All the purification pro-
cedures were completed within 4  h, which means the 
present approach was much faster than the ultracentrif-
ugation method. In a word, we successfully purified HV 
using a one-step affinity chromatography in a time- and 
effort- saving way.
The immunogenicity of CHV
Chromatography-purified CHV was used as a vaccine to 
immunize sea bass juveniles to test the immunogenic-
ity of CHV. The juveniles were vaccinated once or twice 
by intramuscular injection at doses of 15  μg/g FBW 
(H.H. group) and 1.5  μg/g FBW (H.L. group). RBS was 
used as the positive vaccine at the same concentrations 
(V.H. group and V.L. group) for comparison, and PBS 
served as the negative control. Fish sera from vaccinated 
and control sea bass were collected every week, and the 
NNV-specific antibody response was determined by 
antigen-capture ELISA. Figure 6A shows that both H.H. 
and V.H. stimulated levels of NNV-specific antibodies, 
being significantly higher than those of the PBS control 
(p < 0.01) when the fish were immunized once. The anti-
body response induced by CHV was nearly identical to 
that induced by RBS (p > 0.05), and the highest antibody 
titer was obtained at around 5 or 6 weeks post-immuni-
zation. Although H.L. or V.L. stimulated levels of anti-
body responses to a higher level than those induced by 
the PBS control (p  <  0.01), their average antibody titers 
(0.81 U for H.L. or 0.66 U for V.L.) were threefold lower 
than those of H.H. (2.39 U) or V.H. (2.55 U). Therefore, 
immunization was performed twice to enhance the anti-
body response. As shown in Figure 6B, two injections of 
H.H. and V.H. stimulated very high levels of antibodies 
with average titers of 6.49 and 6.1 U, which were two-
fold higher than those obtained in H.H. or V.H. with 
one immunization. The high antibody titers induced by 
H.H. or V.H. remained stable for 10  weeks. Two injec-
tions of H.L. or V.L. improved the average antibody titers 
Figure 5 Purification of HV by nickel-based affinity chroma-
tography. A SDS-PAGE and immunoblotting (IB) of purified HV and 
RBS. M represents protein marker and the HCP bands are indicated 
by an arrow. 2× RBS meant that the loading volume of RBS was two 
folds of those of other HV. B EM of chromatography-purified HV. The 
bar indicates 100 nm.
Figure 6 NNV-specific antibody responses of sea bass juve-
niles. RBS or CHV were used as vaccines in high concentration (V.H. 
or H.H.) and low concentration (V.L. or H.L.) to intramuscularly vac-
cinate sea bass juveniles, and PBS were used as the negative control. 
In each group, sera from 30 randomly selected fish were collected 
every week post-immunization for antigen-capture ELISA to monitor 
the antibody titers. NNV-specific antibody responses of sea bass 
juveniles stimulated by RBS or CHV with one (A) or two (B) injections 
are shown. The letters (a, b, and c) indicate the differentiation analysis 
results of each sample using the Student’s t test. The samples with 
the same letter contained no significant difference (p > 0.05) while 
the samples with different letters held significant difference (p < 0.05).
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by two- to threefold compared with one immunization, 
although their titers were far lower than those obtained 
in H.H or V.H. samples. Nevertheless, the intensity of 
antibody response induced by two injections of H.L. 
was similar to that induced by H.H. with one injection. 
Therefore, the CHV vaccine purified by affinity chroma-
tography was as efficient as RBS in stimulating high titers 
of specific antibodies in Asian sea bass at a dosage of 
15 μg/g FBW (H.H.) with one injection.
The carrying capacity of different insertion sites
Since the sites of N-/C-termini and Ala220 of linker loop 
are suitable positions for his-tag insertion, we went a step 
further to study their carrying capacity. NHV and 220HV 
can carry 16 and 12 amino acids, respectively, while 
CHV accommodates 6 amino acids, meaning that these 
three sites can carry short foreign peptides. To validate 
whether they can accommodate large functional proteins, 
GFP was inserted into these three sites. We found that no 
matter whether GFP fused directly with CP or connected 
to CP with a flexible linker, (GGGGS)3, the GFP-tagged 
CP on sites of N-terminus and Ala220 were unable to 
form VLP even when the fusion proteins were soluble. 
The same result was obtained when GFP fused directly to 
the CP C-terminus. However, when connected with the 
(GGGGS)3 linker, C-terminal GFP-tagged CP is soluble 
and can assemble into GFP-tagged VLP (CGV). The par-
ticle shape of CGV was similar to that of RBS (Figure 7B). 
CGV presents the GFP on the outer surface of particles 
as revealed by immune-EM (Figure  7B). Furthermore, 
the functional GFP can be visualized during the ultracen-
trifugation purification process. An additional file shows 
all the results on CGV production (Additional file  8). 
Therefore, the sites of N-terminus and Ala220 can only 
accommodate short peptides about 12–16 amino acids 
long while the C-terminus can carry functional proteins 
as large as GFP.
Real‑time observation of the entry process of CGV
Invasion assays of CGV were performed to find out 
whether CGV has the ability to invade culture cells, 
which means whether GFP can be carried into the cells 
via VLP as an application for viral vector. The entry pro-
cess of CGV should be recorded in a real-time way by 
inverted fluorescent microscopy directly but not by indi-
rect methods such as IFA. As shown in Figure  8, CGV 
not only can enter SB cells but can finish the entry pro-
cess within 1.5 h, meaning that the entry speed and desti-
nation of CGV were similar to that of RBS. Because CGV 
lacks the cascade amplification of IFA, its overall fluores-
cent signals are weaker than Figure  4. Interestingly, the 
average fluorescent at 4 h post invasion (hpi) was weaker 
than those of 1–1.5  h. However, the GFP was detected 
with a strong fluorescent signal near the nuclei of anti-
GFP antibody in IFA at this time point (Figure  8 IFA). 
These results probably suggest that the VLP structure of 
CGV was disassembled at 4 hpi but the GFP epitope was 
still detected by IFA. Consequently, CGV is suitable for 
viral in-cell traffic research, such as one-virus tracking 
or real-time virus entry study. Moreover, the C-terminus 
Figure 7 GFP tagged VLP production and characterization. A 
GFP insertion design and the additional amino acid sequences. NGCP 
represents the N-terminal GFP-tagged CP, 220GCP represents the 
Ala220 GFP-tagged CP, CGCP indicates the C-terminal GFP-tagged 
CP and (GGGGS)3 represents the flexible linker. The black blocks 
represent CP and the rectangle frames indicate GFP. B Immuno-EM 
was performed to detect the GFP display status of CGV and CGV was 
immune-labeled with 5 nm gold particles using mouse anti-GFP or 
not as first antibody as indicated. The bar indicates 100 nm.
Figure 8 Real-time observation of cell entry of CGV. Puri-
fied CGV was used to invade SB cells and photographed under 
fluorescent microscopy at the time indicated. IFA shows that the 
panel resulted from IFA using anti-GFP as the first antibody. The bar 
indicates 100 µm.
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of CP is an excellent position for accommodating large 
functional proteins with outer surface displaying.
Discussion
The accumulation of high-resolution viral structural infor-
mation has facilitated the ability to modify VLP deliberately. 
Consequently, VLP can essentially function as molecular 
scaffolds for presenting foreign antigens by genetic inser-
tion [32]. Both double- and single-stranded DNA and 
RNA viruses, including 14 families of viruses have been 
successfully generated by the chimeric VLP [33, 34]. Stud-
ies of chimeric VLP in betanodavirus are non-existent and 
the structural information is maintained at approximately 
7.5 Å [35] and 23 Å resolution [36] according to the VLP 
of dragon grouper nervous necrosis virus and malabaricus 
grouper nervous necrosis virus. In this study, we report the 
3D structures of OGNNV at 3.9 Å resolution determined 
by cryo-EM and single-particle reconstruction, and define 
the capsid protein containing N, S and P domains and a 
linker loop as the linkage between the S and P domains. 
Structures of the Flock House Virus (FHV) which belong to 
alphanodavirus have been studied in depth [37]. The crystal 
structure of nematode-infecting virus which is also related 
to the Nodaviridae was recently reported [38]. Compared 
with the reported structures of nodavirus, the canonical 
jelly-roll structure of the S domain is the most common. 
When Dali [39] is used to analyses the homologs of the S 
domain, the OGNNV S domain is best aligned to the nem-
atode-infecting virus (Z score = 10.1) [38], while compared 
to that of FHV, the Z score is only 4.9. Interestingly, the S 
domain has a higher similarity to some plant virus shell 
proteins compared to that of the FHV which is thought 
to be the representative virus of Alphanodavirus. The Z 
score for the comparison to carnation mottle virus [40] and 
maize chlorotic mottle virus [41] is 8.0 and 5.6, respectively. 
In the reported alphanodaviruses, there is no obvious pro-
trusion. The P domain of OGNNV composing a trimeric 
protrusion was similar to that of the nematode-infection 
virus. Although the reported betanodavirus structure is 
only in low resolution, it also showed that there are trimeric 
surface protrusions [36].
The high resolution structure of the capsid allows us 
to identify the structure details and the putative impor-
tant sites for VLP modification. Based on the structural 
results, the N-terminals are located inside the capsid 
shell, and it can be a negative site for outer surface pres-
entation. Ala220 is located at the tip of the capsid surface 
and it is located at the linker which connects the capsid 
shell and the protrusions together. Therefore, we should 
pay more attention to Ala220. Both C-terminus of the 
beta and gamma subunits are packaged inside the cap-
sid shell in the mature alphanodavirus [42], while in the 
betanodavirus, all the C-termini of the CP stick out from 
the capsid shell. Although at the current state, we cannot 
tell the detailed locations of them in the protrusions, we 
can see that the protrusions are at the most outside of the 
RBS and all the C-termini are definitely packaged in the 
protrusions. Therefore, we can set N-/C-termini, Ala220 
of the linker loop and several points among the protru-
sions as candidates that could be target sites for potential 
vaccine design. In the insertion study, different HCP were 
screened by VLP production, showing that the positions 
0, 220, 292 and 338 can carry foreign peptides to assem-
ble into VLP. Our results also show that the C-terminus 
and Ala220 (the linker loop) of CP are valuable sites for 
accommodating foreign peptides on the exterior surface, 
while the N-terminus accepts peptides in the interior of 
VLP, which is consistent with the structural results. Fur-
thermore, the N-terminus and the linker loop can only 
carry short peptides while the C-terminus can accom-
modate large functional proteins such as GFP with a 
flexible linker. Cell invasion assays proved that NHV, 
220HV, CHV and CGV maintain their cell tropism (entry 
receptor[s]) and entry ability (endocytosis pathway) as 
native VLP. Moreover, the application studies of tagged 
VLP show the potential use of C-terminal insertion. Addi-
tion of the His-tag to the C-terminal of CP does not alter 
the structure or immunogenicity of VLP, as proven by fish 
immunization studies, showing that the strategy of adding 
small tags to facilitate purification is feasible and practical 
in VLP vaccine development. It is noteworthy that equal 
dose of VLP induced relatively lower antibody titers in 
sea bass than in groupers [12], suggesting the lower VLP 
susceptibility of sea bass. CGV, the GFP carrying VLP, 
maintains the same entry ability as RBS and can be visu-
alized in real-time for virus position tracking, revealing 
the potential application of viral vector development. To 
the best of our knowledge, this work is the first study to 
describe the exogenous-tagged VLP of betanodavirus.
Many studies have focused on the modification of the 
structure protein of either recombinant viruses or VLP 
to achieve basic structural and application research. For 
example, the core particle of the hepatitis B virus, namely 
HBc, has become one of the most popular carriers for the 
presentation of foreign peptides [43]. The foreign pep-
tides are inserted either into the N-/C-termini of HBc or 
the immunodominant loop region located at the tip of 
the surface ‘‘spikes’’ on HBc particles by genetic fusion 
[44, 45], or linked to native HBc by chemical coupling 
[46], or attached to the fusion binding tag on HBc by pro-
tein–protein interaction [47]. FHV was also utilized as 
a display system to present the receptor von Willebrand 
A domain which can effectively bind the protective anti-
gen of Bacillus anthracis at the surface of FHV VLP. The 
recombinant FHV VLP can neutralize the anthrax intoxi-
cation in vitro and in vivo, exhibiting the display potency 
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of nodavirus VLP [48]. There is no modification study 
on epitope addition or chimeric VLP in betanodavirus, 
except for published reports about point mutation [49, 
50] or terminal deletion [51]. We found that the C-ter-
minus of OGNNV CP can accommodate the His-tag 
and functional GFP without changing the VLP structure, 
suggesting the possible application of the viral vector as 
developed in alphanodavirus.
Betanodaviruses infect many marine fish species [2], 
suggesting their strong infectivity to a wide range of hosts. 
OGNNV VLP can successfully enter several types of fish 
and mammalian cell lines determined by cell entry assays, 
probably via a clathrin-dependent endocytosis pathway 
(unpublished data). Thus, betanodavirus VLP is an eas-
ily delivered viral vector with the ability to enter different 
hosts, especially mammals. In respect of inducing the host’s 
immune response, several types of VLP have been proven 
to activate the innate immune system [52] and cellular 
immune system by pathogen-associated molecular pattern 
motifs [32]. VLP serve not only as scaffolds for presenting 
antigens derived from other pathogens in a suitable repeti-
tive configuration but also as adjuvants to boost the immune 
response [34, 53]. The narrow host range (marine fish) of 
betanodavirus, in particular, may stand a good chance of 
activating the mammalian immune system quickly and vig-
orously because of limited contact between betanodaviruses 
and mammals. Consequently, betanodavirus VLP are per-
fect “self-adjuvanting” immunogen delivery platforms for 
foreign peptides. On the contrary, some researchers have 
added functional foreign peptides to change cell tropism 
[17] by reducing natural virus–cell interactions and confer-
ring the ability to bind to new target receptors, resulting in a 
new strategy for developing novel delivery vehicles.
NHV, the VLP fused with His-tag on the N-terminus, is a 
useful type of viral vessel that differs from 220HV and CHV 
by its enclosed N-terminal His-tag. The key advantage of 
the N-terminal fusion vessel is that the fused short peptides 
can be protected by the VLP shield, which makes the pep-
tides take effect in cells precisely when the VLP are lysed or 
disassembled without the influences of the VLP entry pro-
cess. The His-tags of NHV were proved to be non-detect-
able by anti-His antibodies during immune-EM and IFA 
in cell entry assay when NHV presents as fine structural 
particles. Therefore, the structural completeness of NHV 
can be evaluated by anti-His antibodies against the His-tag 
marker. Thus, the timing and position of lytic virions can 
be revealed in a time-resolved manner. This strategy can 
provide more detailed information on intracellular traffic 
of betanodaviruses after endocytosis and NHV is a good 
tool for studying the betanodavirus endocytosis. A more 
sophisticated but similar strategy to elucidate the endo-
cytosis details has been applied to HIV-1 studies. Time-
resolved single-virus imaging and a virus population-based 
fusion assay were performed to delineate the cellular entry 
sites of HIV-1. The results revealed that complete HIV-1 
fusion occurs in endosomal compartments but not at the 
plasma membrane of epithelial and lymphoid cells [54].
In summary, VLP of the betanodavirus, OGNNV, were 
studied structurally, the key sites for accommodating for-
eign peptides were investigated and the applications of 
easy purification and real-time viral tracking were per-
formed, providing information for potential biotechno-
logical applications.
Additional files
Additional file 1: Primers used in this study. The table shows all the 
primers used in the insertion study.
Additional file 2: The resolution of Cryo-EM structure of OGNNV 
VLP (RBS). The resolution of the Cryo-EM density map is at 3.9 Å evalu-
ated using gold-standard at FSC = 0.143.
Additional file 3: The averaged density distribution of the 3D 
reconstructions. The mass densities of the RBS are spherically averaged 
and plotted as a function of the particle radius. Below a radius of 115 Å 
is the density of enclosed RNA fragments (The RNA fragments do not 
belong to the virus genome, they are arbitrarily enclosed bacterial RNA). 
The density distribution between 115–150 Å and 150–190 Å are the 
capsid and the protrusion respectively. In the capsid shell, each subunit 
arranged in a “jerry-roll” structure results in that the capsid shell looks like 
two layers (two density peaks).
Additional file 4: The side view of an asymmetry unit density map 
superimposed by the models. The density maps are in gray, and the 
ribbon models of VPa, VPb and VPc are colored in the same scheme with 
that of Figures 1D and E. The outside view shows that the Ala220 residue 
(red circles) is at the surface of the capsid while the inside view shows that 
all the residues of the N-terminal of the S domain of VPa and VPb (blue 
circles) are inside the capsid.
Additional file 5: The N-terminal structure of the VPc. The Cut-way 
view of the RBS is shown on left. The zoom in view on the right shows the 
loop (purple) of the N domain identified in VPc. Three VPc form a trident 
structure around the threefold axis.
Additional file 6: Local resolution analysis of RBS. The local resolu-
tion analysis of RBS was performed using the program ResMap. The color 
bar shows the scheme in resolution. The results show that the inner 
capsid has the highest resolution while the loops, especially the loops at 
the surface, are in highest flexibility.
Additional file 7: Expression and solubility of different His-tagged 
CP. Seven His-tagged CP were expressed in their optimal conditions. 
After bacteria cell collection, the samples of whole cells (W) were saved 
and the supernatants (S) and pellets (P) were collected respectively by 
centrifugation after sonication. M represents the protein marker and the 
“+” indicates the sample of purified CP. We can find the solubility of each 
HCP by evaluating the quantity of the CP band in S and P.
Additional file 8: Production and characterization of GFP-tagged 
VLP. (A) SDS-PAGE of three GFP-tagged VLP. Three GFP-tagged CP were 
expressed in their optimal conditions. After bacteria cell collection, the 
samples of whole cells (W) were saved and the supernatants (S) and 
pellets (P) were collected respectively by centrifugation after sonication. 
M represents the protein marker and the arrow indicates the bands of 
fusion protein monomers. (B) Ultracentrifuge tubes in sucrose gradient 
purification of GFP-tagged VLP. The arrows indicate that the bands were 
clearly seen. They were collected, pelleted and resuspended with PBS as 
shown in (C). Light green fluorescent can be seen from the resuspended 
CGV but not from 220GV. The purified CGV and 220GV were observed by 
EM. Fine structured particles were only found in CGV sample (D). The bar 
indicates 100 nm.
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